Note: These positions have been filled for the 2013 - 2014 residency year.
Program Type: ASHP-Accredited PGY2 Oncology
ASHP Match Number: 537860
Purpose: The PGY2 residency in Oncology Pharmacy is a structured 12 month program designed to provide concentrated training focused on the care of patients with cancer and, in some residencies additionally on the care of patients with hematologic disorders. The resident will obtain advanced knowledge and experience in a variety of oncologic diseases and complications. Residents completing the PGY2 Oncology Residency will be highly qualified independent practitioners able to provide and be responsible for drug therapy outcomes for individualized patients as an integral member of the multidisciplinary healthcare team. The knowledge built during the residency will produce a pharmacist who can successfully serve health care organizations as a primary resource for information about anticancer medications. Graduates will have developed their own personal plan for professional development and possess advanced skills to identify the pharmacotherapy and medication-use training needs of other health care professionals caring for individuals with cancer and to deliver effective training to those health care professionals. Residents will also capable of assuming responsibility for identifying and implementing opportunities to improve the medication-use system in oncology practice areas including those involved with the use of investigational agents in clinical trials.
Program Overview: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins is a National Cancer Institute (NCI)-designated Cancer Center and one of the 21 cancer centers within the National Comprehensive Cancer Network. Pharmaceutical care for the oncology patients in the Weinberg Building is provided through a pharmacy satellite located within the facility that operates 24 hours a day. Over the course of a year the resident will become comfortable recognizing and managing cancer- and treatment-related complications, such as pain, infection, alterations in fluids/electrolytes/nutrition, hematologic toxicities and gastrointestinal toxicities. Emphasis will be placed on gaining knowledge and skills to manage and provide recommendations for antineoplastics. Residents will also gain clinical research skills and be involved in different aspects of clinical trials. Upon completion of this residency training, the resident will have developed the clinical skills necessary to practice as an oncology clinical specialist.
- Management of a diverse group of solid and hematologic malignancies
- Familiarity with investigational cancer treatments as well as standard of care
- Multidisciplinary patient care rounds
- Patient and caregiver education
- Multidisciplinary conferences including: Oncology Grand Rounds, Oncology Journal Club, Oncology Pain Conference, and disease-specific case conferences
- Teaching opportunities within the cancer center as well as the University of Maryland School of Pharmacy
Rotations: Ten months are devoted to orientation and core experiences; two months are available for electives. Residents will also participate in a longitudinal Oncology Anticoagulation clinic.
- Core rotations:
- Medical Oncology
- Hematologic Malignancies (2 months)
- Bone Marrow Transplant
- Ambulatory Oncology (2 months)
- Pain and Palliative Care
- Pediatric Oncology
- Oncology Investigational Drug Service
- Elective Rotations:
- Oncology Practice Administration
- Immunocompromised Infectious Disease
- Gynecology Oncology
- Radiation Oncology
All applications will be accepted through PHORCAS
Program Director: Amy Hatfield Seung, Pharm.D., BCOP
Title: Clinical Specialist, Hematologic Malignancies
Education: Doctor of Pharmacy, University of North Carolina
at Chapel Hill
Training: Pharmacy Practice Residency – University of Washington
Oncology Specialty Residency – University of Washington Medical
Center/Seattle Cancer Care Alliance
Dr. Seung is the Hematologic Malignancies Pharmacy Clinical Specialist at The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital. She is also the Director of the PGY-2 Oncology Residency Program at Johns Hopkins and serves as Assistant Clinical Professor with the University of Maryland School of Pharmacy. Dr. Seung received her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill, and completed her Pharmacy Practice and Oncology Specialty Residencies at the University of Washington Medical Center and Seattle Cancer Care Alliance in Seattle, Washington.
Dr. Seung is active in the American Society of Health System Pharmacists as a surveyor for Oncology Residency accreditations and is a past member of the ASHP Council of Education and Workforce Development. She is committed to the education and practices of oncology practitioners and is involved in the Hematology Oncology Pharmacy Association (HOPA). Dr. Seung has served as a member and Chair of the BCOP Recertification Committee.
Dr. Seung was instrumental in the development of the National Comprehensive Cancer Center (NCCN) Standard Chemotherapy Templates and has worked on the NCCN Task Force on Specialty Pharmacy. Dr. Seung has practice and research interests in acute and chronic leukemias, immunocompromised infectious diseases, oncologic emergencies, adverse reactions to chemotherapy, and oncology informatics. She is a national speaker presenting on a variety of oncology topics and has been published in a diversity of media.
Amy Hatfield Seung, Pharm.D., BCOP
Program Director PGY2, Oncology Pharmacy Practice Residency
Department of Pharmacy
The Johns Hopkins Hospital
600 North Wolfe Street / Carnegie 180
Baltimore, Maryland 21287-6180
Phone: (443) 287-5194
Email: ahatfie2 @jhmi.edu